Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants.
Cornelissen, E A; Kollée, L A; De Abreu, R A; van Baal, J M; Motohara, K; Verbruggen, B; Monnens, L A.
Arch Dis Child
; 67(10): 1250-4, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1444522
[CURRENT APPROACHES TO PREVENTION OF BLEEDINGS, ASSOCIATED WITH VITAMIN K DEFICIENCY IN NEWBORNS AND INFANTS].
Vitamin K supplementation for cystic fibrosis.
Impact of supplemental vitamin K1 administration on postoperative blood component requirements after craniosynostosis repair: a prospective, placebo-controlled, randomized, blinded study.
Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates.
Vitamin K, an update for the paediatrician.
High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K<sub>2</sub>, A pre-post intervention clinical trial.
New insights on vitamin K.
Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis.
Coagulopathy in Zellweger spectrum disorders: a role for vitamin K.
Routine use of daily oral vitamin K to treat infants with cystic fibrosis.